Featuring perspectives from Dr Richard Stone, including the following topics:
- Current and future trends in the care of patients with acute myeloid leukemia (AML) (0:00)
- Management of AML with IDH1/2 and FLT3 mutations (17:28)
- Advances in the treatment of high-risk AML (29:42)
- Emerging data with novel therapies for AML with targetable mutations (36:53)
- Hematopoietic stem cell transplantation as a treatment option for patients with relapsed or refractory AML (51:15)
- Advances in the care of patients with myelodysplastic syndromes (56:19)
CME information and select publications